E-LIB Suche - Ergebnisse für: Hernando, Jorge

1

Corrigendum to "Sex differences on multikinase inhibitors t..:

Hernando, Jorge ; Roca-Herrera, Maria ; García-Álvarez, Alejandro...
European Journal of Cancer. , 2024

Link: https://doi.org/10.1016/..

2

DPPA3-HIF1α axis controls colorectal cancer chemoresistance..:

Cuesta-Borràs, Estefania ; Salvans, Cándida ; Arqués, Oriol...
Cell Reports. 42 (2023) 8 - p. 112927 , 2023

Link: https://doi.org/10.1016/..

3

Impact of the COVID-19 pandemic in the early-onset colorect..:

Baraibar, Iosune ; García, Ariadna ; Salvà, Francesc...
Translational Oncology. 32 (2023) - p. 101668 , 2023

Link: https://doi.org/10.1016/..

4

Sex differences on multikinase inhibitors toxicity in patie..:

Hernando, Jorge ; Roca-Herrera, Maria ; García-Álvarez, Alejandro...
European Journal of Cancer. 188 (2023) - p. 39-48 , 2023

Link: https://doi.org/10.1016/..

5

Radiomics and outcome prediction to antiangiogenic treatmen..:

Ligero, Marta ; Hernando, Jorge ; Delgado, Eric...
BJC Reports. 1 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine..:

Mitjavila, Mercedes ; Jimenez-Fonseca, Paula ; Belló, Pilar...
European Journal of Nuclear Medicine and Molecular Imaging. 50 (2023) 8 - p. 2486-2500 , 2023

Link: https://doi.org/10.1007/..

7

Satisfaction with injection experience of patients with neu..:

Hernando, Jorge ; Kolarova, Teodora ; Verslype, Chris...
Journal of Neuroendocrinology. 35 (2023) 6 - p. , 2023

Link: https://doi.org/10.1111/..

8

Corrigendum to 'Coronavirus disease 2019 in patients with n..:

Fazio, Nicola ; Gervaso, Lorenzo ; Halfdanarson, Thorvardur R....
European Journal of Cancer. 160 (2022) - p. 289-290 , 2022

Link: https://doi.org/10.1016/..

9

The impact of COVID‐19 on the management of neuroendocrine ..:

Cives, Mauro ; Hernando, Jorge ; Lamarca, Angela...
Journal of Neuroendocrinology. 34 (2022) 10 - p. , 2022

Link: https://doi.org/10.1111/..

10

What is the status of immunotherapy in thyroid neoplasms?:

Garcia-Alvarez, Alejandro ; Hernando, Jorge ; Carmona-Alonso, Ana.
Frontiers in Endocrinology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Randomized phase II trial of FOLFIRI-panitumumab compared w..:

Aparicio, Jorge ; Virgili Manrique, Anna C. ; Capdevila, Jaume...
Clinical and Translational Oncology. 24 (2022) 11 - p. 2155-2165 , 2022

Link: https://doi.org/10.1007/..

12

Aggressive Pituitary Macroadenoma Treated With Capecitabine..:

Mirallas, Oriol ; Filippi-Arriaga, Francesca ; Hernandez Hernandez, Irene...
Frontiers in Endocrinology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

13

Usefulness of an immunohistochemical score in advanced panc..:

Viúdez, Antonio ; Crespo, Guillermo ; Gómez Dorronsoro, María Luisa...
Pancreatology. 21 (2021) 1 - p. 215-223 , 2021

Link: https://doi.org/10.1016/..

14

Coronavirus disease 2019 in patients with neuroendocrine ne..:

Fazio, Nicola ; Gervaso, Lorenzo ; Halfdanarson, Thorvardur R....
European Journal of Cancer. 154 (2021) - p. 246-252 , 2021

Link: https://doi.org/10.1016/..

15

Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-N..:

Grande, Enrique ; Rodriguez-Antona, Cristina ; López, Carlos...
The Oncologist. 26 (2021) 11 - p. 941-949 , 2021

Link: https://doi.org/10.1002/..